March 6, 2019
rare disease

Rare Disease Situation Analysis

Rare Disease Situation Analysis is aimed at providing a high level glimpse into the rare disease drug development and commercialization. Rare disease drug development has been an increasingly attractive proposition for biopharmaceutical companies.
May 21, 2017

A Quick Overview on FDA Drug Approvals

A quick overview on the novel drug approvals by the FDA over the last 5 years.
February 23, 2017

Infographic – Drug Development Process

From Laboratory Bench to Bedside: the process of developing a new medicine is a complex, time consuming and costly affair. It takes between 10-12 years to move a potential drug from concept to market and can cost the pharmaceutical industry around $2.5B including cost of failures.